 |
|
|
| |
No Detectable Tenofovir Resistance With Tenofovir
Disoproxil Fumarate (TDF) or TDF+Emtricitabine (FTC/TDF)
Through 96 Weeks in Lamivudine-Resistant CHB Patients
|
| |
| |
Reported by Jules Levin
Asian Pacific Association for the Study of the Liver (APASL) Liver Week, June 6-10, 2013, Singapore
Edward Gane1, Amoreena C. Corsa2, Yang Liu2, Ben C. Mitchell2, John F. Flaherty2,
Michael D. Miller2, Kathryn M. Kitrinos2, Scott Fung3
1New Zealand Liver Transplant Unit, Auckland, New Zealand; 2Gilead Sciences, Inc., Foster City, CA, USA; 3Toronto General Hospital, Toronto, Ontario, Canada
|
| |
|
|
|
|
|
